{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:32:35Z","timestamp":1790872355535,"version":"4.1.0"},"reference-count":68,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Staphylococcus aureus frequently colonizes the skin and upper airways and produces a broad repertoire of immunomodulatory molecules. In asthma, the most consistent evidence concerns staphylococcal enterotoxins (SEs), which can act both as superantigens and as allergens, and IgE sensitization to SEs (SE-sIgE). SE-sIgE is associated with severe asthma, type 2 inflammation, chronic rhinosinusitis with nasal polyps (CRSwNP), exacerbations, and, in some longitudinal studies, persistent airflow obstruction. However, this relationship is not necessarily causal: SE-sIgE may reflect exposure, an immune response, or a biologically active endotype, whereas colonization, local toxin production, and systemic sensitization are not equivalent. SEs simultaneously bind class II MHC molecules and Vbeta regions of the T-cell receptor, activating large fractions of T lymphocytes; they also promote IL-4, IL-5, and IL-13 production, polyclonal B-cell activation, local IgE synthesis, mast-cell degranulation, eosinophilia, and IL-8\/neutrophil circuits. Alpha-toxin (Hla) and SEB can damage the epithelial barrier, facilitating allergen penetration and alarmin signalling. These observations support an interaction model in which dysbiosis, barrier dysfunction, and type 2 immunity mutually reinforce one another along the nasobronchial axis. Corticosteroids and antibiotics may modify selected nodes in this circuit, but current evidence is insufficient to recommend decolonization or antitoxin therapy in stable asthma. Biologics interrupt downstream pathways potentially fuelled by toxins: omalizumab neutralizes free IgE; mepolizumab and benralizumab reduce the eosinophilic axis; dupilumab blocks IL-4\/IL-13 signalling; and tezepelumab acts upstream on TSLP. Nevertheless, randomized trials stratified by SE-sIgE are lacking, and no evidence demonstrates that these treatments eliminate colonization or toxin production. SE-sIgE therefore appears to be a promising biomarker, particularly in severe asthma with CRSwNP, but it is not yet an autonomous criterion for biologic selection. A broader barrier-organ analysis also identifies nasal, cutaneous, and intestinal colonization as distinct ecological states; atopic dermatitis as a complementary model of toxin-amplified type 2 inflammation; and biofilms and extracellular vesicles as candidate mechanisms of persistent toxin delivery. These data increase biological plausibility but remain indirect for asthma.<\/jats:p>","DOI":"10.3390\/toxins18080319","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:11:42Z","timestamp":1784787102000},"page":"319","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Staphylococcus Aureus Toxins and Asthma: Pathophysiological Mechanisms, Clinical Relevance, and Therapeutic Implications in the Biologics Era"],"prefix":"10.3390","volume":"18","author":[{"given":"Diego","family":"Bagnasco","sequence":"first","affiliation":[{"name":"Respiratory and Allergy Clinic, IRCCS Azienda Ospedaliera Metropolitana (AOM), Plesso: Ospedale Policlinico San Martino, Largo Rosanna Benzi, 16132 Genoa, Italy"},{"name":"Department of Internal Medicine (DIMI), University of Genoa, Viale Benedetto XV, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Bondi","sequence":"additional","affiliation":[{"name":"Respiratory and Allergy Clinic, IRCCS Azienda Ospedaliera Metropolitana (AOM), Plesso: Ospedale Policlinico San Martino, Largo Rosanna Benzi, 16132 Genoa, Italy"},{"name":"Department of Internal Medicine (DIMI), University of Genoa, Viale Benedetto XV, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Losacco","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (DIMI), University of Genoa, Viale Benedetto XV, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Montagnino","sequence":"additional","affiliation":[{"name":"Respiratory and Allergy Clinic, IRCCS Azienda Ospedaliera Metropolitana (AOM), Plesso: Ospedale Policlinico San Martino, Largo Rosanna Benzi, 16132 Genoa, Italy"},{"name":"Department of Internal Medicine (DIMI), University of Genoa, Viale Benedetto XV, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Froio","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, Largo Francesco Vito, 00168 Rome, Italy"},{"name":"UOSD Allergology and Clinical Immunology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tedesco","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, Largo Francesco Vito, 00168 Rome, Italy"},{"name":"UOSD Allergology and Clinical Immunology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"D\u2019Alessandro","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, Largo Francesco Vito, 00168 Rome, Italy"},{"name":"UOSD Allergology and Clinical Immunology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Baglivo","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, Largo Francesco Vito, 00168 Rome, Italy"},{"name":"UOSD Allergology and Clinical Immunology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bruno","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, Largo Francesco Vito, 00168 Rome, Italy"},{"name":"UOSD Allergology and Clinical Immunology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Chiappori","sequence":"additional","affiliation":[{"name":"Respiratory and Allergy Clinic, IRCCS Azienda Ospedaliera Metropolitana (AOM), Plesso: Ospedale Policlinico San Martino, Largo Rosanna Benzi, 16132 Genoa, Italy"},{"name":"Department of Internal Medicine (DIMI), University of Genoa, Viale Benedetto XV, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Murillo Jaramillo","sequence":"additional","affiliation":[{"name":"Respiratory and Allergy Clinic, IRCCS Azienda Ospedaliera Metropolitana (AOM), Plesso: Ospedale Policlinico San Martino, Largo Rosanna Benzi, 16132 Genoa, Italy"},{"name":"Department of Internal Medicine (DIMI), University of Genoa, Viale Benedetto XV, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Mincarini","sequence":"additional","affiliation":[{"name":"Respiratory and Allergy Clinic, IRCCS Azienda Ospedaliera Metropolitana (AOM), Plesso: Ospedale Policlinico San Martino, Largo Rosanna Benzi, 16132 Genoa, Italy"},{"name":"Department of Internal Medicine (DIMI), University of Genoa, Viale Benedetto XV, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Braido","sequence":"additional","affiliation":[{"name":"Respiratory and Allergy Clinic, IRCCS Azienda Ospedaliera Metropolitana (AOM), Plesso: Ospedale Policlinico San Martino, Largo Rosanna Benzi, 16132 Genoa, Italy"},{"name":"Department of Internal Medicine (DIMI), University of Genoa, Viale Benedetto XV, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-029X","authenticated-orcid":false,"given":"Cristiano","family":"Caruso","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Universit\u00e0 Cattolica del Sacro Cuore, Largo Francesco Vito, 00168 Rome, Italy"},{"name":"UOSD Allergology and Clinical Immunology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"ref_1","unstructured":"Global Initiative for Asthma (2025). Global Strategy for Asthma Management and Prevention, 2025 Update, GINA. Available online: https:\/\/ginasthma.org\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Touaitia, R., Mairi, A., Ibrahim, N.A., Basher, N.S., Idres, T., and Touati, A. (2025). Staphylococcus aureus: A review of the pathogenesis and virulence mechanisms. Antibiotics, 14.","DOI":"10.3390\/antibiotics14050470"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gehrke, A.K.E., Giai, C., and Gomez, M.I. (2023). Staphylococcus aureus adaptation to the skin in health and persistent\/recurrent infections. Antibiotics, 12.","DOI":"10.3390\/antibiotics12101520"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41579-023-00852-y","article-title":"Staphylococcus aureus host interactions and adaptation","volume":"21","author":"Howden","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Fisher, E.L., Otto, M., and Cheung, G.Y.C. (2018). Basis of virulence in enterotoxin-mediated staphylococcal food poisoning. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00436"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Tam, K., and Torres, V.J. (2019). Staphylococcus aureus secreted toxins and extracellular enzymes. Microbiol. Spectr., 7.","DOI":"10.1128\/microbiolspec.GPP3-0039-2018"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","article-title":"Pathogenicity and virulence of Staphylococcus aureus","volume":"12","author":"Cheung","year":"2021","journal-title":"Virulence"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5415\/apallergy.2013.3.2.120","article-title":"Staphylococcal enterotoxin specific IgE and asthma: A systematic review and meta-analysis","volume":"3","author":"Song","year":"2013","journal-title":"Asia Pac. Allergy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/cea.12652","article-title":"Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly","volume":"46","author":"Song","year":"2016","journal-title":"Clin. Exp. Allergy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1900198","DOI":"10.1183\/13993003.00198-2019","article-title":"Sensitisation to staphylococcal enterotoxins and asthma severity: A longitudinal study in the EGEA cohort","volume":"54","author":"Sintobin","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/all.15466","article-title":"Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity","volume":"78","author":"Caruso","year":"2023","journal-title":"Allergy"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sakr, A., Bregeon, F., Mege, J.M., Rolain, J.M., and Blin, O. (2018). Staphylococcus aureus nasal colonization: An update on mechanisms, epidemiology, risk factors, and subsequent infections. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.02419"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10096-008-0602-7","article-title":"Intestinal carriage of Staphylococcus aureus: How does its frequency compare with that of nasal carriage and what is its clinical impact?","volume":"28","author":"Acton","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Liu, A., Garrett, S., Hong, W., and Zhang, J. (2024). Staphylococcus aureus infections and human intestinal microbiota. Pathogens, 13.","DOI":"10.3390\/pathogens13040276"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00281-011-0292-6","article-title":"Innate and adaptive immune responses against Staphylococcus aureus skin infections","volume":"34","author":"Krishna","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro3521","article-title":"Staphylococcal manipulation of host immune responses","volume":"13","author":"Thammavongsa","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_18","first-page":"2","article-title":"Immune evasion by Staphylococcus aureus","volume":"7","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"ftx005","DOI":"10.1093\/femspd\/ftx005","article-title":"Staphylococcus aureus pathogenesis in diverse host environments","volume":"75","author":"Balasubramanian","year":"2017","journal-title":"Pathog. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dong, D., Ni, Q., Wang, C., Zhang, L., Li, Z., Jiang, C., Mao, E., and Peng, Y. (2018). Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3111-z"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Krakauer, T. (2019). Staphylococcal superantigens: Pyrogenic toxins induce toxic shock. Toxins, 11.","DOI":"10.3390\/toxins11030178"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1165\/rcmb.2016-0207OC","article-title":"Staphylococcus aureus alpha-toxin induces actin filament remodeling in human airway epithelial model cells","volume":"58","author":"Ziesemer","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"M\u00f6ller, N., Ziesemer, S., Hildebrandt, P., Assenheimer, N., Deigner, H.P., and Hildebrandt, J.P. (2020). S. aureus alpha-toxin monomer binding and heptamer formation in host cell membranes: Do they determine sensitivity of airway epithelial cells toward the toxin?. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0233854"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Eiffler, I., Behnke, J., Ziesemer, S., M\u00fcller, C., and Hildebrandt, J.P. (2016). ATP release from human airway epithelial cells exposed to Staphylococcus aureus alpha-toxin. Toxins, 8.","DOI":"10.3390\/toxins8120365"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","article-title":"Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma","volume":"126","author":"Bachert","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1002\/pmic.200900338","article-title":"Gram-positive bacteria produce membrane vesicles","volume":"9","author":"Lee","year":"2009","journal-title":"Proteomics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1398-9995.2010.02483.x","article-title":"Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation","volume":"66","author":"Hong","year":"2011","journal-title":"Allergy"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hong, S.W., Choi, E.-B., Min, T.-K., Kim, J.-H., Kim, M.-H., Jeon, S.G., Lee, B.-J., Gho, Y.S., Jee, Y.-K., and Pyun, B.-Y. (2014). An important role of alpha-hemolysin in extracellular vesicles on the development of atopic dermatitis induced by Staphylococcus aureus. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100499"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tim.2017.11.008","article-title":"Staphylococcus aureus and atopic dermatitis: A complex and evolving relationship","volume":"26","author":"Geoghegan","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/81385","article-title":"Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1","volume":"6","author":"Amagai","year":"2000","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/viru.2.5.17724","article-title":"Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease","volume":"2","author":"Archer","year":"2011","journal-title":"Virulence"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamadermatol.2013.8627","article-title":"The presence and impact of biofilm-producing staphylococci in atopic dermatitis","volume":"150","author":"Allen","year":"2014","journal-title":"JAMA Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jaci.2021.03.016","article-title":"What is the contribution of IgE to nasal polyposis?","volume":"147","author":"Bachert","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1465-9921-7-115","article-title":"Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells","volume":"7","author":"Riddell","year":"2006","journal-title":"Respir. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cea.13760","article-title":"Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrity","volume":"51","author":"Martens","year":"2021","journal-title":"Clin. Exp. Allergy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jaci.2023.10.033","article-title":"Staphylococcus aureus lysate induces an IgE response via memory B cells in nasal polyps","volume":"153","author":"Du","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jaci.2017.01.019","article-title":"Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation","volume":"139","author":"Gevaert","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_38","first-page":"PA641","article-title":"Impact of staphylococcus aureus enterotoxins on clinical responses to omalizumab in severe asthma patients","volume":"62","author":"Wu","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"De Corso, E., Mele, D.A., Rizzi, A., Spanu, C., Corb\u00f2, M., Pisciottano, S., Mastrapasqua, R.F., Baroni, S., Porru, D.P., and De Maio, G. (2024). Sinonasal outcomes obtained after 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and CRSwNP: A real-life observational study. J. Pers. Med., 14.","DOI":"10.3390\/jpm14091014"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4168\/aair.2023.15.2.160","article-title":"Staphylococcal enterotoxin-specific IgE sensitization: A potential predictor of fixed airflow obstruction in elderly asthma","volume":"15","author":"Won","year":"2023","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1067\/mai.2000.105807","article-title":"Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens","volume":"105","author":"Hauk","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Schoini, P., Apollonatou, V., Kallieri, M., Blizou, M., Sfika, M., Koufopoulos, N., Pouliakis, A., Liatsis, E., Foukas, P., and Bakakos, P. (2024). Sensitization to Staphylococcus enterotoxin: Relationship with aspects of disease severity. J. Clin. Med., 13.","DOI":"10.3390\/jcm13195836"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"adv00164","DOI":"10.2340\/00015555-3514","article-title":"Skin microbiome in atopic dermatitis","volume":"100","author":"Edslev","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.anai.2017.10.037","article-title":"The atopic march: Critical evidence and clinical relevance","volume":"120","author":"Hill","year":"2018","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/bjd.14566","article-title":"Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: A systematic review and meta-analysis","volume":"175","author":"Totte","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.anai.2018.12.003","article-title":"The role of the skin microbiome in atopic dermatitis","volume":"122","author":"Nakatsuji","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/jid.2014.43","article-title":"Th2 cytokines increase Staphylococcus aureus alpha-toxin-induced keratinocyte death through STAT6","volume":"134","author":"Brauweiler","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaci.2012.10.030","article-title":"Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal alpha-toxin-induced keratinocyte death","volume":"131","author":"Brauweiler","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: A new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/586746","article-title":"Superantigen profile of Staphylococcus aureus in steroid-resistant atopic dermatitis","volume":"46","author":"Schlievert","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.18176\/jiaci.0573","article-title":"Relationship between IgE-mediated sensitization to Staphylococcus aureus enterotoxin B, asthma severity, and atopy","volume":"31","author":"Barranco","year":"2021","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100464","DOI":"10.1016\/j.waojou.2020.100464","article-title":"Oral corticosteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)","volume":"13","author":"Canonica","year":"2020","journal-title":"World Allergy Organ. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): A randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/femsre\/fuz030","article-title":"Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms","volume":"44","author":"Miller","year":"2020","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/S2666-5247(22)00322-6","article-title":"Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: A phase 2, double-blind, randomised, placebo-controlled trial","volume":"4","author":"Piewngam","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Wei, Y., Gong, J., Zhu, W., Guo, D., Gu, L., Li, N., and Li, J. (2015). Fecal microbiota transplantation restores dysbiosis in patients with methicillin-resistant Staphylococcus aureus enterocolitis. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-0973-1"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Bagnasco, D., Nicola, S., Testino, E., Brussino, L., Pini, L., Caminati, M., Piccardo, F., Canevari, R.F., Melissari, L., and Ioppi, A. (2023). Long-term efficacy of mepolizumab at 3 years in patients with severe asthma: Comparison with clinical trials and super responders. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092424"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Pini, L., Bagnasco, D., Begh\u00e8, B., Braido, F., Cameli, P., Caminati, M., Caruso, C., Crimi, C., Guarnieri, G., and Latorre, M. (2024). Unlocking the long-term effectiveness of benralizumab in severe eosinophilic asthma: A three-year real-life study. J. Clin. Med., 13.","DOI":"10.20944\/preprints202402.1390.v1"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"108198","DOI":"10.1016\/j.rmed.2025.108198","article-title":"ICS use trajectories in severe asthma patients on benralizumab: Real-life data from 3-years follow-up","volume":"245","author":"Pini","year":"2025","journal-title":"Respir. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and SINUS-52): Results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Bagnasco, D., Bondi, B., Brussino, L., Nicola, S., Cameli, P., Tiotiu, A., Guida, G., Gollinucci, C., Visca, D., and Spanevello, A. (2025). Dupilumab effectiveness in patients with severe allergic asthma non-responsive to omalizumab. J. Pers. Med., 15.","DOI":"10.3390\/jpm15020043"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Corren","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.14425","article-title":"EAACI biologicals guidelines-Recommendations for severe asthma","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1111\/all.15089","article-title":"Advances and highlights in biomarkers of allergic diseases","volume":"76","author":"Ogulur","year":"2021","journal-title":"Allergy"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/8\/319\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:16:21Z","timestamp":1784787381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/8\/319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["toxins18080319"],"URL":"https:\/\/doi.org\/10.3390\/toxins18080319","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}